Skip to main content

Investors raise stake in over 170 companies in Q1; 11 of them turn multibaggers

Stocks which have more than doubled so far in the year 2020 include names like Aarti Drugs, AGC Network, Suzlon, Dixon Technologies, Granules India, Eveready Industries, etc. among others.

The influx of retail investors into the market in 2020 suggests that the new-age millennials have the cash and are not afraid of taking risk. Retail investors raised stake in more than 170 companies in the June quarter.

The stocks of 11 of them have gained more than 100 percent in 2020 so far.

The new-age investors seem like millennials in nature. They are no longer conservative and want to explore new options for generating alpha.

According to a media report, data from the Securities and Exchange Board of India (SEBI) showed that investors opened a record 2.4 million demat accounts in the June quarter, or 5.6 percent of the total number of such accounts, reflecting the growing retail participation in stock markets. In the six months ended June 30, 3.9 million accounts were added.

Stocks that have more than doubled so far in the year 2020 include names like Aarti Drugs, AGC Network, Suzlon, Dixon Technologies, Granules India, and Eveready Industries.



Experts are of the view that most of the stocks in the list are from the small & midcaps space. They are at best trading play and investors should book profits while stocks like  Dixon Technologies, Aarti Drugs, Vaibhav Global, and Granules India.

“Of the 12 stocks under consideration, 3 are penny stocks, 5 are going through turbulent times due to various reasons. Investors cannot consider these stocks worthy of long-term investment based on current financial strength or promoter pledges or poor financial performance,” Tejas Khoday, CEO and Co-Founder, FYERS told Moneycontrol.

“The best stocks among these 12 would be Dixon Technologies, Aarti Drugs, Vaibhav Global and Granules India. Traders who have chosen the first set of 8 stocks have gone with the flow and made money,” he said.

Small & Midcaps top picks:

Retail investors raised stake in 173 companies and about 17 percent of them are in the large-cap space with a market cap of over Rs 20,000 cr while almost 80 percent of the companies are from the small, mid, and micro-cap space, data from AceEquity showed.

 

Some of the large-cap names in which retail investors raised stake include names like HDFC Bank, HUL, Bharti Airtel, Kotak Mahindra Bank, Wipro, Axis Bank, HDFC Life Insurance Company, Britannia Industries, Dabur India, M&M, Dr Reddy's Laboratories, and Tech Mahindra, etc. among others.

 




After the outbreak of COVID-19 across the world including India, measures introduced by the government favoured small & mid-cap space, and that could be one big reason why money started to move in the broader markets apart from attractive valuations.

Over a 3-year period, Nifty50 has given a return of 15 percent, while the Nifty Mid-cap index is still down 7 percent, and the small-cap index is down by 27 percent. Hence, there is still a lot of ground to cover.

“While the data shows that retail investors preferred small and midcaps - a proxy for higher growth, these were the very same stocks which were beaten down the most in the March bottom,” Siddharth Panjwani, Chief Strategy Officer Pickright Technologies told Moneycontrol.

“Retail investors have shown some rationality when the market was placing a huge discount for these companies and bought stocks in the hope that the growth is higher than market expectations. The question is whether this growth will pan out in the Indian context,” he said.

Will the party last?

Post March the only direction in which equity markets were headed was up. The liquidity wave took all boats in one direction and that is higher – so retail investors or Robinhood investors have very little role to play when it comes to pushing markets higher.

Anecdotal data suggest that ever since the global financial crisis in 2008, investors have seen Central bank puts in place measures to support the economy which has in turn lifted equity markets across the globe.



SD Solutions advises users to check with certified experts before taking any investment decisions.

Source – Moneycontrol.com

Comments

Post a Comment

Popular posts from this blog

Panacea Biotech shares hit 5% upper circuit after dengue vaccine completes phase I & II study

DengiAIl induced robust neutralising antibody responses against all the four dengue virus serotypes, the company has said in an exchange filing. Panacea Biotech share price hit 5 percent upper circuit on the BSE on September 24 after the company completed phases I and II study of its dengue vaccine candidate DengiAIl. "Panacea Biotec Ltd. is delighted to announce the successful completion of its Phase I/II study to evaluate the safety and immunogenicity of its vaccine, DengiAll, a single-dose liveattenuated tetravalent vaccine," the company said in an exchange filing. Live-attenuated vaccines contain weakened bacteria or viruses that trigger an immune response but do not cause disease. The company said DengiAIl induced robust neutralising antibody responses against all the four dengue virus serotypes. DengiAIl has been found to be safe and well-tolerated with no serious adverse effects, the company said. After a single-dose, more than 80 percent of the participants ...
Post a Comment
Read more

Check Chemcon Speciality Chemicals IPO allotment status in four simple steps

Equity shares will get credited into the accounts of eligible investors by September 30 and the listing of equity shares will be on October 1, 2020. Chemcon Speciality Chemicals, the manufacturer for pharmaceutical and oilfields industries, is expected to announce the basis of allotment early next week. As per the schedule provided by the company, the finalisation of the basis of the allotment will be done by September 28 and the initiation of refunds or unblocking of funds from ASBA account will take place on September 29. Equity shares will get credited to the accounts of eligible investors by September 30 and the listing will be on October The IPO comprised a fresh issue of Rs 165 crore and an offer for sale of Rs 153 crore by promoters. The company will utilise fresh issue proceeds for expansion of manufacturing facility, working capital requirements, and general corporate purposes. Chemcon manufactures specialised chemicals, such as Hexamethyldisilazane (HMDS) and Chloromethyl Iso...
Post a Comment
Read more

Taking Stock | Profit-booking pulls Nifty below 14,450; Sensex drops 549 points

  All the sectoral indices ended in the red with IT and PSU bank indices falling 2 percent each. The market remained under pressure on January 15 on the back of profit-booking across sectors amid weak global cues. At close, the Sensex was down 549.49 points or 1.11% at 49,034.67, and Nifty was down 161.90 points or 1.11% at 14,433.70. "The market witnessed profit-booking and following global trends. Nifty continues to resist 14,600 and has taken a dip towards 14,360. If the market closes below 14,380 levels, we might see a correction till the levels of 14,180-14,200. Momentum indicators like RSI, MACD are indicating a small correction in the markets," said Ashis Biswas, Head of Research at CapitalVia Global Research. All the sectoral indices ended in the red with IT and PSU bank falling 2 percent each. Broader markets performed in line with the main indices with BSE Midcap and Smallcap indices falling 1 percent each. Tech Mahindra, GAIL, HCL Tech, Wipro and ONGC...
Post a Comment
Read more